Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Hain Celestial Group Inc

NASDAQ: HAIN · Manufacturing · 5 alerts · CIK 910406

Share price
$0.1233Close, Nov 16
Market cap
$11.2M
Shares outstanding
91MLatest SEC cover page
Sector
Manufacturing
Industry
Food and Kindred ProductsSIC 2000

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Hain Celestial Group Inc filings on SEC EDGAR ↗

4:08 PM ET 10-Q
Financial Results

Hain Celestial Group Q1 2026 Results: Net Loss of $11.3M, Loss Narrows

For the quarter ended September 30, 2026, Hain Celestial reported net sales of $260.3 million, a decrease from $367.9 million in the prior year period. The company recorded a net loss of $11.3 million, which was an improvement over the $20.6 million net loss reported in the same quarter of 2025. Management highlighted strategic initiatives including the pending sale of their International business.

Key figure
Net loss $11.3M
7:08 AM ET 8-K
Financial Results

Hain Celestial Group Financial Results

Hain Celestial reported fiscal first quarter 2027 results with net sales of $260 million, a 29% year-over-year decrease primarily driven by divestitures and brand exits. The company also announced it received final regulatory approvals for the sale of its International business to AURELIUS, though it missed a credit agreement amendment deadline and remains in discussions to complete the deal.

Term
Q1 2027

“During the first quarter, we made progress on our strategic actions to realign our cost structure, drive productivity, and improve our commercial and innovation capabilities. We saw our gross margin improve meaningfully year over year, reflecting progress on both our commercial and portfolio actions. We remain focused on simplifying our operating model and creating a stronger go-forward Hain.”

Alison Lewis, President and CEO

“Receiving the final required regulatory approvals is an important step toward completing the sale of our International business. We remain in discussions with our lenders regarding our capital structure and with AURELIUS regarding a path forward for the transaction. If completed, the International sale would allow us to reduce debt and create a more focused North America business with strong brands in attractive categories.”

Alison Lewis, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.